Indication

Synovial sarcoma

Synovial sarcoma is a rare, high-grade soft tissue malignancy of uncertain cellular differentiation that most frequently affects adolescents and young adults. Read more about Synovial sarcoma

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Synovial sarcoma therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Synovial sarcoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Synovial sarcoma.

Synovial sarcoma is a rare, high-grade soft tissue malignancy of uncertain cellular differentiation that most frequently affects adolescents and young adults.

The disease primarily develops in the deep soft tissues of the extremities—especially near large joints in the legs and arms—though it can also arise in the trunk, abdomen, lungs, and head or neck region.

Clinically, it often presents as an indolent or slow-growing deep mass, with a marked propensity for local recurrence and late hematogenous metastasis, most commonly to the lungs.

Pathophysiologically, it is defined by a characteristic reciprocal chromosomal translocation, t(X;18)(p11.2;q11.2), which results in the oncogenic *SS18-SSX* fusion gene that drives aberrant transcriptional regulation and tumor pathogenesis.

Personalize your experience

Follow Synovial sarcoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it